PI3K/Akt signalling pathway and cancer.
J. Á. Fresno Vara,
E. Casado,
J. de Castro,
P. Cejas,
C. Belda-Iniesta,
M. González-Barón
|
11 |
2004 |
11
2004
|
Metastatic bone disease: clinical features, pathophysiology and treatment strategies.
R. Coleman
|
10 |
2001 |
10
2001
|
Molecular mechanisms of resistance and toxicity associated with platinating agents.
C. Rabik,
M. Dolan
|
10 |
2007 |
10
2007
|
The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.
D. McMillan
|
10 |
2013 |
10
2013
|
Osteosarcoma treatment - where do we stand? A state of the art review.
Anja Luetke,
P. Meyers,
I. Lewis,
H. Juergens
|
10 |
2014 |
10
2014
|
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
9 auth.
R. Tokunaga,
Wu Zhang,
M. Naseem,
A. Puccini,
M. D. Berger,
S. Soni,
...
M. McSkane,
H. Baba,
H. Lenz
|
9 |
2018 |
9
2018
|
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.
K. Gupta,
Jeffrey D. Miller,
Jim Z. Li,
M. Russell,
C. Charbonneau
|
9 |
2008 |
9
2008
|
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment.
A. Gupte,
R. Mumper
|
9 |
2009 |
9
2009
|
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Nithya Krishnamurthy,
R. Kurzrock
|
9 |
2018 |
9
2018
|
New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin.
M. Li‐Weber
|
9 |
2009 |
9
2009
|
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.
E. Newlands,
M. Stevens,
S. Wedge,
R. Wheelhouse,
C. Brock
|
9 |
1997 |
9
1997
|
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
7 auth.
Josep Garcia,
H. Hurwitz,
A. Sandler,
D. Miles,
R. Coleman,
R. Deurloo,
...
O. Chinot
|
9 |
2020 |
9
2020
|
Interleukin-6 signaling pathway in targeted therapy for cancer.
Yuqi Guo,
Feng Xu,
T. Lu,
Z. Duan,
Zhan Zhang
|
9 |
2012 |
9
2012
|
Primary bone osteosarcoma in the pediatric age: state of the art.
A. Longhi,
C. Errani,
M. De Paolis,
M. Mercuri,
G. Bacci
|
9 |
2006 |
9
2006
|
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.
P. Eroles,
A. Bosch,
J. Pérez-Fidalgo,
A. Lluch
|
9 |
2012 |
9
2012
|
The proteasome: structure, function, and role in the cell.
Julian Adams
|
9 |
2003 |
9
2003
|
Management of toxicities of immune checkpoint inhibitors.
L. Spain,
S. Diem,
J. Larkin
|
9 |
2016 |
9
2016
|
